PMC:7205724 / 39-150
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":93,"end":108},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":" Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, a"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":50,"end":74},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_35705"}],"text":" Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, a"}
LitCovid-sample-MedDRA
{"project":"LitCovid-sample-MedDRA","denotations":[{"id":"T1","span":{"begin":93,"end":108},"obj":"http://purl.bioontology.org/ontology/MEDDRA/10022891"}],"attributes":[{"id":"A1","pred":"meddra_id","subj":"T1","obj":"http://purl.bioontology.org/ontology/MEDDRA/10021496"}],"text":" Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, a"}
LitCovid-sample-PD-IDO
{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T1","span":{"begin":50,"end":67},"obj":"http://purl.obolibrary.org/obo/IDO_0000610"}],"text":" Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, a"}
LitCovid-sample-sentences
{"project":"LitCovid-sample-sentences","denotations":[{"id":"T2","span":{"begin":1,"end":75},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, a"}
LitCovid-sample-Enju
{"project":"LitCovid-sample-Enju","denotations":[{"id":"T6","span":{"begin":1,"end":10},"obj":"NN"},{"id":"T7","span":{"begin":11,"end":14},"obj":"CC"},{"id":"T8","span":{"begin":15,"end":25},"obj":"NN"},{"id":"T9","span":{"begin":26,"end":29},"obj":"IN"},{"id":"T10","span":{"begin":30,"end":33},"obj":"DT"},{"id":"T11","span":{"begin":34,"end":37},"obj":"NN"},{"id":"T12","span":{"begin":38,"end":40},"obj":"IN"},{"id":"T13","span":{"begin":41,"end":49},"obj":"JJ"},{"id":"T14","span":{"begin":50,"end":67},"obj":"JJ"},{"id":"T15","span":{"begin":68,"end":74},"obj":"NNS"},{"id":"T16","span":{"begin":74,"end":75},"obj":"-COLON-"},{"id":"T17","span":{"begin":76,"end":91},"obj":"NNS"},{"id":"T18","span":{"begin":91,"end":92},"obj":"-COMMA-"},{"id":"T19","span":{"begin":93,"end":108},"obj":"NNS"},{"id":"T20","span":{"begin":108,"end":109},"obj":"-COMMA-"}],"relations":[{"id":"R5","pred":"arg1Of","subj":"T6","obj":"T7"},{"id":"R6","pred":"arg2Of","subj":"T8","obj":"T7"},{"id":"R7","pred":"arg1Of","subj":"T7","obj":"T9"},{"id":"R8","pred":"arg2Of","subj":"T11","obj":"T9"},{"id":"R9","pred":"arg1Of","subj":"T11","obj":"T10"},{"id":"R10","pred":"arg1Of","subj":"T11","obj":"T12"},{"id":"R11","pred":"arg2Of","subj":"T15","obj":"T12"},{"id":"R12","pred":"arg1Of","subj":"T15","obj":"T13"},{"id":"R13","pred":"arg1Of","subj":"T15","obj":"T14"},{"id":"R14","pred":"arg1Of","subj":"T7","obj":"T16"},{"id":"R15","pred":"arg1Of","subj":"T17","obj":"T18"},{"id":"R16","pred":"arg2Of","subj":"T19","obj":"T18"}],"text":" Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, a"}
LitCovid-sample-PD-FMA
{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T1","span":{"begin":93,"end":108},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":" Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, a"}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T2","span":{"begin":1,"end":75},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, a"}